Prolonged paralysis and apnea after receiving a neuromuscular blocking agent: What nurses should know

American Journal of Critical Care

Volumn 18, Issue 6, 2009, Pages 588-591

  Jaramillo, Kathryn S ^a   Scruth, Elizabeth ^b   Cheng, Eugene ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Educational Services ^*  (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; ISOQUINOLINE DERIVATIVE; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT;

AMPUTATION; APNEA; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; MIDDLE AGED; NURSING; PARALYSIS;

AMPUTATION; APNEA; FEMALE; HUMANS; ISOQUINOLINES; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; PARALYSIS; PSEUDOCHOLINESTERASE;

EID: 74049146203     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2009572     Document Type: Article

References (23)

1. Kendrick K. Prolonged paralysis related to mivacurium: a case study. J Perianesth Nurs. 2005;20(1):7-12.
2. Leadingham CL. A case of pseudocholinesterase deficiency in the PACU. J Perianesth Nurs. 2007;22(4):265-274.
3. Niazi A, Leonard IE, O'Kelly B. Prolonged neuromuscular blockade as a result of malnutrition-induced pseudocholinesterase deficiency. J Clin Anesth. 2004;16(1):40-42.
4. Kervin MW. Residual neuromuscular blockade in the immediate postoperative period. J Perianesth Nurs. 2002;17(3):152-158.
5. Williams M, Young RM, Milner QJ. Prolonged paralysis following sequential mivacurium administration. Anaesthesia. 2003;58(10):1032-1033.
6. Imerman B, Caruso LJ, Zori RT. Prolonged neuromuscular block in a patient undergoing renal transplantation. J Clin Anesth. 2001;13(7):540-544.
7. Lockride O. Genetic variants of human butyrylcholinesterase influence the metabolism of the muscle relaxant succinylcholine. In: Kalow W, ed. Pharmacogenomics of Drug Metabolism. Oxford, United Kingdom: Pergamon Press; 1992:15-50.
8. Rees JE. Suxamethonium apnoea. Pract Proc. 2005;19:1.
9. Dell DD, Kehoe C. Plasma cholinesterase deficiency. J Perianesth Nurs. 1996;11(5):304-308.
10. Ahdal OA, Bevan DR. Clindamycin-induced neuromuscular blockade. Can J Anaesth. 1995;42(7):614-617.
11. Alexander DR. Serum cholinesterase. Medline Plus Medical Encyclopedia. http://www.nlm.nih.gov/medlineplus /ency/article/003358.htm. Accessed August 31, 2009.
12. Ballard N, Robley L, Barrett D, Fraser D, Mendoza I. Patients' recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care. 2006;15(1):86-94.
13. Herr K, Coyne PJ, Manworren R, et al. Pain assessment in the nonverbal patient: position statement with clinical practice recommendations. Pain Manage Nurs. 2006;7(2):44-52.
14. Shapiro BA, Warren J, Egol A, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Crit Care Med. 1995;23(9):1596-1600.
15. Wesley E, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation Sedation Scale (RASS). JAMA. 2003;289:2983-2991.
16. Van Gammeren AJ, Cobbaert CM, Schrauwen CJM. Fresh frozen plasma transfusion for reversal of prolonged postanesthesia apnea. Transfus Med. 2008;18(2):134-136.
17. Cholinesterase. In: Price Evans DA, ed. Genetic Factors in Drug Therapy: Clinical and Molecular Pharmacogenetics. Cambridge, United Kingdom: Cambridge University Press; 1993:137-175.
18. Weinshilboum R. Inheritance and drug response. N Engl J Med. 2003;348(6):529-537.
19. Galley HF, Mahdy A, Lowes DA. Pharmacogenetics and anesthesiologists. Pharmacogenomics. 2005;6(8):849-856.
20. Lando G, Mosca A, Bonora R, et al. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian population study. Pharmacogenetics. 2003;13(5):265-270.
21. Vaisi-Raygani A, Rahimi Z, Kharazi H, et al. Determination of butyrylcholinesterase phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran. Clin Biochem. 2007; 40(9-10):629-633.
22. Yen T, Nightingale BN, Burns JC, et al. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in Australian population. Clin Chem. 2003;49(8):1297-1308.
23. Gatke MR, Bundgaard JR, Viby-Mogensen J. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anesthesia. Pharmacogen Genomics. 2007;17(11):995-999.